Allergy and Infectious Diseases Research in South Carolina
Allergy and Infectious Diseases Research (93.855) awarded $65.0 million to recipients in South Carolina in 70 grants from fiscal 2021 to 2025, 0.3% of the program's national total. University of South Carolina received the most, $29.8 million.
- Awarded in South Carolina$65.0 million
- Awards70
- Share of the program0.3%
- Rank among states34th of 52
- National total$22 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 27 | $13.1 million |
| FY 2022 | 31 | $10.0 million |
| FY 2023 | 39 | $15.8 million |
| FY 2024 | 30 | $15.2 million |
| FY 2025 | 26 | $10.8 million |
Recipients in South Carolina
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| University of South Carolina | Colleges and universities | 27 | $29.8 million |
| Nubad LLC | Small businesses | 8 | $11.4 million |
| The Medical University of South Carolina | Colleges and universities | 13 | $8.8 million |
| Clemson University | Colleges and universities | 12 | $7.5 million |
| VRM Labs, Inc. | Small businesses | 2 | $2.4 million |
| Expanse Bio LLC | Small businesses | 1 | $2.0 million |
| Zylo Therapeutics, Inc. | Small businesses | 2 | $900,000 |
| Acepre, LLC | Small businesses | 2 | $897,310 |
| Sylvatica Biotech Inc | Small businesses | 1 | $629,908 |
| University of South Carolina | Colleges and universities | 1 | $406,504 |
Open opportunities under this program
- Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)
- Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)
- Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)
- Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
- Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- Immune Tolerance Network (UM1 Clinical Trial Required)
- Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed)
- NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, and AI (T15 Independent Clinical Trial Not Allowed)
- Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed)
See all 93 on the program page
Questions people ask
How much Allergy and Infectious Diseases Research money goes to South Carolina?
$65.0 million from fiscal 2021 to 2025, across 70 awards. South Carolina ranks 34th of 52 states and territories for this program.
Who receives Allergy and Infectious Diseases Research money in South Carolina?
The largest recipient is University of South Carolina, with $29.8 million in 27 awards. Next are Nubad LLC and The Medical University of South Carolina.
Can organizations in South Carolina apply now?
Yes, 93 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Allergy and Infectious Diseases Research in other states
Other large programs in South Carolina
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- National School Lunch Program
- Child Care and Development Block Grant
- Title I Grants to Local Educational Agencies
- Special Education Grants to States
- Children's Health Insurance Program
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- Head Start